Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Martin I. Voskuil

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-IMM MICRO GENERAL OPER
Phone303/724-4219

    Collapse Research 
    Collapse research activities and funding
    R21AI171065     (VOSKUIL, MARTIN INUA)Apr 1, 2023 - Mar 31, 2025
    NIH
    BEYOND BURDEN: NEW TOOLS FOR TUBERCULOSIS ANTIBIOTICREGIMEN DESIGN
    Role: Principal Investigator
    R21AI131215     (VOSKUIL, MARTIN INUA)Feb 15, 2018 - Jan 31, 2021
    NIH
    Iron-dependence of clofazimine activity in mycobacteria
    Role: Principal Investigator
    R21AI135652     (WALTER, NICHOLAS D)Jan 10, 2018 - Dec 31, 2019
    NIH
    Precursor-rRNA profiling as a measure of drug activity in tuberculosis
    Role: Co-Principal Investigator
    R21AI120458     (VOSKUIL, MARTIN INUA)Jun 15, 2015 - May 31, 2018
    NIH
    Population heterogeneity in Mycobacterium tuberculosis
    Role: Principal Investigator
    R01AI061505     (VOSKUIL, MARTIN INUA)Jul 1, 2004 - Feb 28, 2017
    NIH
    The Mycobacterium Tuberculosis Dormancy Program
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wynn EA, Dide-Agossou C, Reichlen M, Rossmassler K, Al Mubarak R, Reid JJ, Tabor ST, Born SEM, Ransom MR, Davidson RM, Walton KN, Benoit JB, Hoppers A, Loy DE, Bauman AA, Massoudi LM, Dolganov G, Strong M, Nahid P, Voskuil MI, Robertson GT, Moore CM, Walter ND. Transcriptional adaptation of Mycobacterium tuberculosis that survives prolonged multi-drug treatment in mice. mBio. 2023 Oct 31; e0236323. PMID: 37905920.
      View in: PubMed
    2. Born SEM, Reichlen MJ, Bartek IL, Benoit JB, Frank DN, Voskuil MI. Population heterogeneity in Mycobacterium smegmatis and Mycobacterium abscessus. Microbiology (Reading). 2023 10; 169(10). PMID: 37862100.
      View in: PubMed
    3. Walter ND, Ernest JP, Dide-Agossou C, Bauman AA, Ramey ME, Rossmassler K, Massoudi LM, Pauly S, Al Mubarak R, Voskuil MI, Kaya F, Sarathy JP, Zimmerman MD, Dartois V, Podell BK, Savic RM, Robertson GT. Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses. Antimicrob Agents Chemother. 2023 09 19; 67(9):e0028423. PMID: 37565762.
      View in: PubMed
    4. Wynn EA, Dide-Agossou C, Reichlen M, Rossmassler K, Al Mubarak R, Reid JJ, Tabor ST, Born SEM, Ransom MR, Davidson RM, Walton KN, Benoit JB, Hoppers A, Bauman AA, Massoudi LM, Dolganov G, Nahid P, Voskuil MI, Robertson GT, Moore CM, Walter ND. Transcriptional adaptation of drug-tolerant Mycobacterium tuberculosis in mice. bioRxiv. 2023 Mar 08. PMID: 36945388.
      View in: PubMed
    5. Reichlen MJ, Born SEM, Lyons MA, Rossmassler K, Reid J, Robertson GT, Walter ND, Voskuil MI. Standardized RS Ratio Metrics To Assess Tuberculosis Antimicrobial Efficacy and Potency. Antimicrob Agents Chemother. 2023 01 24; 67(1):e0148322. PMID: 36622159.
      View in: PubMed
    6. Dide-Agossou C, Bauman AA, Ramey ME, Rossmassler K, Al Mubarak R, Pauly S, Voskuil MI, Garcia-Cremades M, Savic RM, Nahid P, Moore CM, Tasneen R, Nuermberger EL, Robertson GT, Walter ND. Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments. Antimicrob Agents Chemother. 2022 04 19; 66(4):e0231021. PMID: 35311519.
      View in: PubMed
    7. Musisi E, Dide-Agossou C, Al Mubarak R, Rossmassler K, Ssesolo AW, Kaswabuli S, Byanyima P, Sanyu I, Zawedde J, Worodria W, Voskuil MI, Savic RM, Nahid P, Davis JL, Huang L, Moore CM, Walter ND. Reproducibility of the Ribosomal RNA Synthesis Ratio in Sputum and Association with Markers of Mycobacterium tuberculosis Burden. Microbiol Spectr. 2021 10 31; 9(2):e0048121. PMID: 34494858.
      View in: PubMed
    8. Walter ND, Born SEM, Robertson GT, Reichlen M, Dide-Agossou C, Ektnitphong VA, Rossmassler K, Ramey ME, Bauman AA, Ozols V, Bearrows SC, Schoolnik G, Dolganov G, Garcia B, Musisi E, Worodria W, Huang L, Davis JL, Nguyen NV, Nguyen HV, Nguyen ATV, Phan H, Wilusz C, Podell BK, Sanoussi ND, de Jong BC, Merle CS, Affolabi D, McIlleron H, Garcia-Cremades M, Maidji E, Eshun-Wilson F, Aguilar-Rodriguez B, Karthikeyan D, Mdluli K, Bansbach C, Lenaerts AJ, Savic RM, Nahid P, V?squez JJ, Voskuil MI. Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens. Nat Commun. 2021 05 18; 12(1):2899. PMID: 34006838.
      View in: PubMed
    9. Grosse-Siestrup BT, Gupta T, Helms S, Tucker SL, Voskuil MI, Quinn FD, Karls RK. A Role for Mycobacterium tuberculosis Sigma Factor C in Copper Nutritional Immunity. Int J Mol Sci. 2021 Feb 20; 22(4). PMID: 33672733.
      View in: PubMed
    10. Flores-Valdez MA, Aceves-S?nchez MJ, Peterson EJR, Baliga N, Bravo-Madrigal J, De la Cruz-Villegas M?, Ares MA, Born S, Voskuil M, P?rez-Padilla NA, Burciaga-Flores M, Camacho-Villegas TA, Espinoza-Jorge MG. Transcriptional portrait of M. bovis BCG during biofilm production shows genes differentially expressed during intercellular aggregation and substrate attachment. Sci Rep. 2020 07 28; 10(1):12578. PMID: 32724037.
      View in: PubMed
    11. Alqaseer K, Turapov O, Barthe P, Jagatia H, De Visch A, Roumestand C, Wegrzyn M, Bartek IL, Voskuil MI, O'Hare HM, Ajuh P, Bottrill AR, Witney AA, Cohen-Gonsaud M, Waddell SJ, Mukamolova GV. Protein kinase B controls Mycobacterium tuberculosis growth via phosphorylation of the transcriptional regulator Lsr2 at threonine 112. Mol Microbiol. 2019 12; 112(6):1847-1862. PMID: 31562654.
      View in: PubMed
    12. Voskuil MI, Covey CR, Walter ND. Antibiotic Lethality and Membrane Bioenergetics. Adv Microb Physiol. 2018; 73:77-122. PMID: 30262111.
      View in: PubMed
    13. Reichlen MJ, Leistikow RL, Scobey MS, Born SEM, Voskuil MI. Anaerobic Mycobacterium tuberculosis Cell Death Stems from Intracellular Acidification Mitigated by the DosR Regulon. J Bacteriol. 2017 12 01; 199(23). PMID: 28874407.
      View in: PubMed
    14. Tischler AD, Leistikow RL, Ramakrishnan P, Voskuil MI, McKinney JD. Mycobacterium tuberculosis Phosphate Uptake System Component PstA2 Is Not Required for Gene Regulation or Virulence. PLoS One. 2016; 11(8):e0161467. PMID: 27557082.
      View in: PubMed
    15. Bartek IL, Reichlen MJ, Honaker RW, Leistikow RL, Clambey ET, Scobey MS, Hinds AB, Born SE, Covey CR, Schurr MJ, Lenaerts AJ, Voskuil MI. Antibiotic Bactericidal Activity Is Countered by Maintaining pH Homeostasis in Mycobacterium smegmatis. mSphere. 2016 Jul-Aug; 1(4). PMID: 27579369.
      View in: PubMed
    16. Walter ND, de Jong BC, Garcia BJ, Dolganov GM, Worodria W, Byanyima P, Musisi E, Huang L, Chan ED, Van TT, Antonio M, Ayorinde A, Kato-Maeda M, Nahid P, Leung AM, Yen A, Fingerlin TE, Kechris K, Strong M, Voskuil MI, Davis JL, Schoolnik GK. Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients. J Infect Dis. 2016 10 15; 214(8):1205-11. PMID: 27534685.
      View in: PubMed
    17. Garcia BJ, Loxton AG, Dolganov GM, Van TT, Davis JL, de Jong BC, Voskuil MI, Leach SM, Schoolnik GK, Walzl G, Strong M, Walter ND. Sputum is a surrogate for bronchoalveolar lavage for monitoring Mycobacterium tuberculosis transcriptional profiles in TB patients. Tuberculosis (Edinb). 2016 09; 100:89-94. PMID: 27553415.
      View in: PubMed
    18. Irwin SM, Prideaux B, Lyon ER, Zimmerman MD, Brooks EJ, Schrupp CA, Chen C, Reichlen MJ, Asay BC, Voskuil MI, Nuermberger EL, Andries K, Lyons MA, Dartois V, Lenaerts AJ. Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice. ACS Infect Dis. 2016 Apr 08; 2(4):251-267. PMID: 27227164.
      View in: PubMed
    19. Voskuil MI, Schlesinger LS. Toward Resolving the Paradox of the Critical Role of the DosR Regulon in Mycobacterium tuberculosis Persistence and Active Disease. Am J Respir Crit Care Med. 2015 May 15; 191(10):1103-5. PMID: 25978571.
      View in: PubMed
    20. Walter ND, Dolganov GM, Garcia BJ, Worodria W, Andama A, Musisi E, Ayakaka I, Van TT, Voskuil MI, de Jong BC, Davidson RM, Fingerlin TE, Kechris K, Palmer C, Nahid P, Daley CL, Geraci M, Huang L, Cattamanchi A, Strong M, Schoolnik GK, Davis JL. Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis. J Infect Dis. 2015 Sep 15; 212(6):990-8. PMID: 25762787.
      View in: PubMed
    21. Austin CR, Goodyear AW, Bartek IL, Stewart A, Sutherland MD, Silva EB, Zweifel A, Vitko NP, Tuanyok A, Highnam G, Mittelman D, Keim P, Schweizer HP, V?zquez-Torres A, Dow SW, Voskuil MI. A Burkholderia pseudomallei colony variant necessary for gastric colonization. mBio. 2015 Feb 03; 6(1). PMID: 25650400.
      View in: PubMed
    22. Sohaskey CD, Voskuil MI. In vitro models that utilize hypoxia to induce non-replicating persistence in Mycobacteria. Methods Mol Biol. 2015; 1285:201-13. PMID: 25779317.
      View in: PubMed
    23. Jones-Carson J, Zweifel AE, Tapscott T, Austin C, Brown JM, Jones KL, Voskuil MI, V?zquez-Torres A. Nitric oxide from IFN?-primed macrophages modulates the antimicrobial activity of ?-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal Salmonella. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3079. PMID: 25121731.
      View in: PubMed
    24. Bartek IL, Woolhiser LK, Baughn AD, Basaraba RJ, Jacobs WR, Lenaerts AJ, Voskuil MI. Mycobacterium tuberculosis Lsr2 is a global transcriptional regulator required for adaptation to changing oxygen levels and virulence. mBio. 2014 Jun 03; 5(3):e01106-14. PMID: 24895305.
      View in: PubMed
    25. Irwin SM, Gruppo V, Brooks E, Gilliland J, Scherman M, Reichlen MJ, Leistikow R, Kramnik I, Nuermberger EL, Voskuil MI, Lenaerts AJ. Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas. Antimicrob Agents Chemother. 2014 Jul; 58(7):4026-34. PMID: 24798275.
      View in: PubMed
    26. Voskuil MI. Mycobacterium tuberculosis cholesterol catabolism requires a new class of acyl coenzyme A dehydrogenase. J Bacteriol. 2013 Oct; 195(19):4319-21. PMID: 23893117.
      View in: PubMed
    27. Plimpton SR, Golkowski M, Mitchell DG, Austin C, Eaton SS, Eaton GR, Golkowski C, Voskuil M. Remote delivery of hydroxyl radicals via secondary chemistry of a nonthermal plasma effluent. Biotechnol Bioeng. 2013 Jul; 110(7):1936-44. PMID: 23359480.
      View in: PubMed
    28. Tischler AD, Leistikow RL, Kirksey MA, Voskuil MI, McKinney JD. Mycobacterium tuberculosis requires phosphate-responsive gene regulation to resist host immunity. Infect Immun. 2013 Jan; 81(1):317-28. PMID: 23132496.
      View in: PubMed
    29. Brugarolas P, Movahedzadeh F, Wang Y, Zhang N, Bartek IL, Gao YN, Voskuil MI, Franzblau SG, He C. The oxidation-sensing regulator (MosR) is a new redox-dependent transcription factor in Mycobacterium tuberculosis. J Biol Chem. 2012 Nov 02; 287(45):37703-12. PMID: 22992749.
      View in: PubMed
    30. Jones-Carson J, Laughlin JR, Stewart AL, Voskuil MI, V?zquez-Torres A. Nitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei. Nitric Oxide. 2012 Jun 30; 27(1):25-31. PMID: 22521523.
      View in: PubMed
    31. Voskuil MI, Bartek IL, Visconti K, Schoolnik GK. The response of mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front Microbiol. 2011; 2:105. PMID: 21734908.
      View in: PubMed
    32. Hamad MA, Austin CR, Stewart AL, Higgins M, V?zquez-Torres A, Voskuil MI. Adaptation and antibiotic tolerance of anaerobic Burkholderia pseudomallei. Antimicrob Agents Chemother. 2011 Jul; 55(7):3313-23. PMID: 21537012.
      View in: PubMed
    33. Jiang Z, Higgins MP, Whitehurst J, Kisich KO, Voskuil MI, Hodges RS. Anti-tuberculosis activity of a-helical antimicrobial peptides: de novo designed L- and D-enantiomers versus L- and D-LL-37. Protein Pept Lett. 2011 Mar; 18(3):241-52. PMID: 20858205.
      View in: PubMed
    34. Honaker RW, Dhiman RK, Narayanasamy P, Crick DC, Voskuil MI. DosS responds to a reduced electron transport system to induce the Mycobacterium tuberculosis DosR regulon. J Bacteriol. 2010 Dec; 192(24):6447-55. PMID: 20952575.
      View in: PubMed
    35. Ryan GJ, Hoff DR, Driver ER, Voskuil MI, Gonzalez-Juarrero M, Basaraba RJ, Crick DC, Spencer JS, Lenaerts AJ. Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach. PLoS One. 2010 Jun 14; 5(6):e11108. PMID: 20559431.
      View in: PubMed
    36. Christensen JB, Vitko NP, Voskuil MI, Castillo-Mancilla JR. Implantable cardiac defibrillator pocket infection due to a previously undescribed Cupriavidus species. J Clin Microbiol. 2010 Jul; 48(7):2623-5. PMID: 20427695.
      View in: PubMed
    37. Leistikow RL, Morton RA, Bartek IL, Frimpong I, Wagner K, Voskuil MI. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol. 2010 Mar; 192(6):1662-70. PMID: 20023019.
      View in: PubMed
    38. Singh A, Crossman DK, Mai D, Guidry L, Voskuil MI, Renfrow MB, Steyn AJ. Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response. PLoS Pathog. 2009 Aug; 5(8):e1000545. PMID: 19680450.
      View in: PubMed
    39. Font?n PA, Voskuil MI, Gomez M, Tan D, Pardini M, Manganelli R, Fattorini L, Schoolnik GK, Smith I. The Mycobacterium tuberculosis sigma factor sigmaB is required for full response to cell envelope stress and hypoxia in vitro, but it is dispensable for in vivo growth. J Bacteriol. 2009 Sep; 191(18):5628-33. PMID: 19592585.
      View in: PubMed
    40. Bartek IL, Rutherford R, Gruppo V, Morton RA, Morris RP, Klein MR, Visconti KC, Ryan GJ, Schoolnik GK, Lenaerts A, Voskuil MI. The DosR regulon of M. tuberculosis and antibacterial tolerance. Tuberculosis (Edinb). 2009 Jul; 89(4):310-6. PMID: 19577518.
      View in: PubMed
    41. Honaker RW, Leistikow RL, Bartek IL, Voskuil MI. Unique roles of DosT and DosS in DosR regulon induction and Mycobacterium tuberculosis dormancy. Infect Immun. 2009 Aug; 77(8):3258-63. PMID: 19487478.
      View in: PubMed
    42. Hamad MA, Zajdowicz SL, Holmes RK, Voskuil MI. An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei. Gene. 2009 Feb 01; 430(1-2):123-31. PMID: 19010402.
      View in: PubMed
    43. Jones-Carson J, Laughlin J, Hamad MA, Stewart AL, Voskuil MI, V?zquez-Torres A. Inactivation of [Fe-S] metalloproteins mediates nitric oxide-dependent killing of Burkholderia mallei. PLoS One. 2008 Apr 09; 3(4):e1976. PMID: 18398486.
      View in: PubMed
    44. Honaker RW, Stewart A, Schittone S, Izzo A, Klein MR, Voskuil MI. Mycobacterium bovis BCG vaccine strains lack narK2 and narX induction and exhibit altered phenotypes during dormancy. Infect Immun. 2008 Jun; 76(6):2587-93. PMID: 18362135.
      View in: PubMed
    45. Roback P, Beard J, Baumann D, Gille C, Henry K, Krohn S, Wiste H, Voskuil MI, Rainville C, Rutherford R. A predicted operon map for Mycobacterium tuberculosis. Nucleic Acids Res. 2007; 35(15):5085-95. PMID: 17652327.
      View in: PubMed
    46. Lin MY, Geluk A, Smith SG, Stewart AL, Friggen AH, Franken KL, Verduyn MJ, van Meijgaarden KE, Voskuil MI, Dockrell HM, Huygen K, Ottenhoff TH, Klein MR. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun. 2007 Jul; 75(7):3523-30. PMID: 17502400.
      View in: PubMed
    47. Leyten EM, Lin MY, Franken KL, Friggen AH, Prins C, van Meijgaarden KE, Voskuil MI, Weldingh K, Andersen P, Schoolnik GK, Arend SM, Ottenhoff TH, Klein MR. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 2006 Jul; 8(8):2052-60. PMID: 16931093.
      View in: PubMed
    48. Voskuil MI. Mycobacterium tuberculosis gene expression during environmental conditions associated with latency. Tuberculosis (Edinb). 2004; 84(3-4):138-43. PMID: 15207483.
      View in: PubMed
    49. Voskuil MI, Visconti KC, Schoolnik GK. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb). 2004; 84(3-4):218-27. PMID: 15207491.
      View in: PubMed
    50. Gao Q, Kripke K, Arinc Z, Voskuil M, Small P. Comparative expression studies of a complex phenotype: cord formation in Mycobacterium tuberculosis. Tuberculosis (Edinb). 2004; 84(3-4):188-96. PMID: 15207488.
      View in: PubMed
    51. Voskuil MI, Schnappinger D, Rutherford R, Liu Y, Schoolnik GK. Regulation of the Mycobacterium tuberculosis PE/PPE genes. Tuberculosis (Edinb). 2004; 84(3-4):256-62. PMID: 15207495.
      View in: PubMed
    52. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C, Schoolnik GK. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med. 2003 Sep 01; 198(5):693-704. PMID: 12953091.
      View in: PubMed
    53. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med. 2003 Sep 01; 198(5):705-13. PMID: 12953092.
      View in: PubMed
    54. Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, Tompa M, Schoolnik GK, Sherman DR. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol. 2003 May; 48(3):833-43. PMID: 12694625.
      View in: PubMed
    55. Voskuil MI, Chambliss GH. The TRTGn motif stabilizes the transcription initiation open complex. J Mol Biol. 2002 Sep 20; 322(3):521-32. PMID: 12225746.
      View in: PubMed
    56. Manganelli R, Voskuil MI, Schoolnik GK, Dubnau E, Gomez M, Smith I. Role of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression. Mol Microbiol. 2002 Jul; 45(2):365-74. PMID: 12123450.
      View in: PubMed
    57. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. Proc Natl Acad Sci U S A. 2001 Jun 19; 98(13):7534-9. PMID: 11416222.
      View in: PubMed
    58. Wilson M, Voskuil M, Schnappinger D, Schoolnik GK. Functional Genomics of Mycobacterium tuberculosis Using DNA Microarrays. Methods Mol Med. 2001; 54:335-57. PMID: 21341086.
      View in: PubMed
    59. Kim JH, Voskuil MI, Chambliss GH. NADP, corepressor for the Bacillus catabolite control protein CcpA. Proc Natl Acad Sci U S A. 1998 Aug 04; 95(16):9590-5. PMID: 9689125.
      View in: PubMed
    60. Voskuil MI, Chambliss GH. The -16 region of Bacillus subtilis and other gram-positive bacterial promoters. Nucleic Acids Res. 1998 Aug 01; 26(15):3584-90. PMID: 9671823.
      View in: PubMed
    61. Voskuil MI, Chambliss GH. Significance of HPr in catabolite repression of alpha-amylase. J Bacteriol. 1996 Dec; 178(23):7014-5. PMID: 8955329.
      View in: PubMed
    62. Voskuil MI, Voepel K, Chambliss GH. The -16 region, a vital sequence for the utilization of a promoter in Bacillus subtilis and Escherichia coli. Mol Microbiol. 1995 Jul; 17(2):271-9. PMID: 7494476.
      View in: PubMed
    63. Voskuil MI, Chambliss GH. Rapid isolation and sequencing of purified plasmid DNA from Bacillus subtilis. Appl Environ Microbiol. 1993 Apr; 59(4):1138-42. PMID: 8476287.
      View in: PubMed
    Voskuil's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (262) concept(s)
    _
    Co-Authors Expand Description
    See all (13) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)